A blog chronicling the evolution and implementation of cannabis laws in the United States
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.
The federal Food and Drug Administration (FDA) is currently soliciting public comments about the therapeutic benefits and abuse liability of various controlled substances, including cannabidiol (CBD).
As of January 2017, 29 states have legalized medical marijuana. However, marijuana remains a Schedule l substance under the Controlled Substances Act. Substances in Schedule l are determined by the Food and Drug Administration (FDA) to have no medical use, and states that allow the use of marijuana for medical use violate federal law.
Continue Reading Food and Drug Administration’s Regulation of Cannabis
